(Q40754403)

reason for preferred rank

23 September 2017

title

Interferon-α therapy in patients with Kaposi's Sarcoma and the acquired immunodeficiency syndrome (English)

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

3 December 2022

Interferon-alpha therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1823908

3 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

3 December 2022

author name string

J. Paredes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1823908

3 December 2022

S. E. Krown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1823908

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1823908

3 December 2022

publication date

1 January 1991

1 reference

full work available at URL

23 September 2017

https://api.elsevier.com/content/article/PII:019205619190128T?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

https://api.elsevier.com/content/article/PII:019205619190128T?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

International Journal of Immunopharmacology

3 December 2022

published in

1 reference

23 September 2017

volume

13 Suppl 1

1 reference

23 September 2017

page(s)

77-81

1 reference

Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma

23 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Interferon-??2a in the Treatment of Acquired Immunodeficiency Syndrome-Related Kaposi??s Sarcoma

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Antibody patterns to herpesviruses in kaposi's sarcoma: Serological association of european kaposi's sarcoma with cytomegalovirus

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of american Kaposi's sarcoma with cytomegalovirus

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Herpes-Type Virus Particles in Tissue Culture of Kaposi's Sarcoma From Different Geographic Regions2

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

3 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial

3 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Severe acquired immune deficiency syndrome in male homosexuals: diminished capacity to make interferon-alpha in vitro associated with severe opportunistic infections

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapy

3 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Kaposi's sarcoma in organ transplant recipients: report of 20 cases

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Effect of Interferon on Murine Leukaemia Virus Infection. IV. Formation of Non-infectious Virus in Chronically Infected Cells

3 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon

3 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

3 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

3 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90128-T

3 December 2022

Identifiers

1 reference

23 September 2017

1 reference